Crewe Advisors LLC Pfizer Inc Transaction History

Crewe Advisors LLC

$859 Million
Q3 2024

A detailed history of Crewe Advisors LLC transactions in Pfizer Inc stock. As of the latest transaction made, Crewe Advisors LLC holds 14,470 shares of PFE stock, worth $374,628. This represents 0.05% of its overall portfolio holdings.

Number of Shares

14,470

Previous 14,656 1.27%

Holding current value

$374,628

Previous $410,000 1.95%

% of portfolio

0.05%

Previous 0.05%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$27.7 - $31.39 $5,152 - $5,838	-186 Reduced 1.27%	14,470 $418,000
Q2 2024 Jul 29, 2024	SELL	$25.26 - $29.6 $2,374 - $2,782	-94 Reduced 0.64%	14,656 $410,000
Q1 2024 May 13, 2024	BUY	$25.89 - $29.73 $381,877 - $438,517	14,750 New	14,750 $409,000
Q2 2023 Jul 28, 2023	SELL	$36.12 - $41.79 $42,332 - $48,977	-1,172 Reduced 8.15%	13,205 $484,000
Q1 2023 May 12, 2023	BUY	$39.39 - $51.28 $9,020 - $11,743	229 Added 1.62%	14,377 $586,000
Q4 2022 Feb 07, 2023	SELL	$41.75 - $54.5 $57,072 - $74,501	-1,367 Reduced 8.81%	14,148 $725,000
Q3 2022 Nov 14, 2022	BUY	$43.76 - $53.42 $33,695 - $41,133	770 Added 5.22%	15,515 $679,000
Q2 2022 Aug 02, 2022	BUY	$46.53 - $55.17 $95,526 - $113,264	2,053 Added 16.18%	14,745 $773,000
Q1 2022 Apr 27, 2022	BUY	$45.75 - $56.69 $168,726 - $209,072	3,688 Added 40.96%	12,692 $657,000
Q4 2021 Feb 10, 2022	BUY	$41.32 - $61.25 $22,726 - $33,687	550 Added 6.51%	9,004 $532,000
Q3 2021 Oct 29, 2021	SELL	$39.25 - $50.42 $2,158 - $2,773	-55 Reduced 0.65%	8,454 $364,000
Q2 2021 Aug 11, 2021	SELL	$35.91 - $40.68 $71,784 - $81,319	-1,999 Reduced 19.02%	8,509 $333,000
Q1 2021 Apr 21, 2021	BUY	$33.49 - $37.77 $5,291 - $5,967	158 Added 1.53%	10,508 $381,000
Q4 2020 Jan 27, 2021	BUY	$33.47 - $42.56 $83,541 - $106,229	2,496 Added 31.78%	10,350 $381,000
Q3 2020 Oct 13, 2020	BUY	$31.75 - $37.25 $51,562 - $60,494	1,624 Added 26.07%	7,854 $288,000
Q1 2020 May 07, 2020	SELL	$27.03 - $38.62 $1,865 - $2,664	-69 Reduced 1.1%	6,230 $203,000
Q4 2019 Feb 05, 2020	BUY	$32.92 - $37.36 $2,271 - $2,577	69 Added 1.11%	6,299 $247,000
Q3 2019 Nov 06, 2019	SELL	$32.49 - $42.13 $1,234 - $1,600	-38 Reduced 0.61%	6,230 $224,000
Q1 2019 May 10, 2019	BUY	$37.5 - $41.2 $1,425 - $1,565	38 Added 0.61%	6,268 $266,000
Q3 2018 Nov 13, 2018	BUY	$34.47 - $41.81 $214,748 - $260,476	6,230 New	6,230 $275,000

Others Institutions Holding PFE

# of Institutions

3,261

Shares Held

3.62B

Call Options Held

77.2M

Put Options Held

122M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $145B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Crewe Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Crewe Advisors LLC with notifications on news.

Account

Crewe Advisors LLC Pfizer Inc Transaction History